Non-Surgical Knee Procedure Offers Lasting Pain Relief for Arthritis Patients

A non-surgical procedure that temporarily blocks excess blood vessels in the knee has demonstrated the potential to provide lasting pain relief for individuals suffering from knee osteoarthritis. According to a clinical study involving 194 patients, 80% experienced substantial reductions in knee pain that persisted for at least one year following the treatment.

This development offers a promising alternative for the millions of adults dealing with chronic joint pain who may have exhausted pain medication or steroid injection options but wish to avoid total knee replacement surgery. Osteoarthritis is characterized by the wearing down of joint cartilage, which can lead to the growth of unnecessary blood vessels around the knee. These extra vessels can increase inflammation and irritate surrounding nerves, resulting in painful movement.

The procedure, known as genicular artery embolization (GAE), directly addresses this issue. By temporarily clogging these aberrant blood vessels, doctors can reduce inflammation and consequently diminish pain signals without resorting to invasive surgery or permanent implants. The treatment utilizes microscopic gelatin particles that dissolve over time, leaving no foreign material in the body. Researchers suggest that if widely adopted, GAE could offer a repeatable, low-risk method for patients to maintain activity levels and preserve joint function for longer periods.

Florian Nima Fleckenstein, M.D., deputy head of Interventional Radiology at Charité-Universitätsmedizin Berlin, stated in a press release that a treatment gap exists for many patients with knee osteoarthritis. He added that their study indicates GAE, using rapidly resorbable gelatin-based microspheres, is a safe, minimally invasive therapy that provides significant pain relief and functional improvement in patients with osteoarthritis-related knee symptoms for at least 12 months.

During the GAE procedure, physicians use real-time X-ray guidance to navigate a thin catheter into the blood vessels surrounding the knee joint. Tiny, dissolvable gelatin particles are then introduced into specific vessels to reduce excess blood flow to inflamed areas.

In the study, across 239 total procedures performed on 194 participants, no severe complications were reported. Mild side effects, such as temporary skin discoloration or minor bruising, occurred in only 6.7% of cases and resolved on their own. Fleckenstein noted that participants observed a significant decrease in pain and a notable increase in function, encompassing improvements in sports, recreation, and daily activities, leading to a substantial increase in their overall quality of life.

Beyond pain reduction, patients reported enhanced mobility, including easier walking, stair climbing, and bending. Their quality-of-life scores more than doubled during the 12-month follow-up period.

Study Limitations

Despite the encouraging results, the researchers highlighted several limitations. The study did not include a control group that received a placebo procedure, making it challenging to definitively attribute the observed physical benefits solely to the dissolvable particles versus potential placebo effects. Furthermore, the study's follow-up period extended only to one year, necessitating further research to ascertain the long-term duration of pain relief and the potential need for repeat treatments.

While GAE shows efficacy in reducing inflammation and pain, the researchers emphasized that it is not a cure for osteoarthritis. The procedure does not rebuild lost cartilage or reverse existing structural joint damage. Larger, randomized trials are currently underway to validate these initial findings.